<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK5941" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK5941/" /><meta name="ncbi_pagename" content="Glycogen Storage Disease Type VI - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Glycogen Storage Disease Type VI - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Glycogen Storage Disease Type VI" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/11/27" /><meta name="citation_author" content="Emma Labrador" /><meta name="citation_author" content="David A Weinstein" /><meta name="citation_pmid" content="20301760" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK5941/" /><meta name="citation_keywords" content="GSD VI" /><meta name="citation_keywords" content="GSD VI" /><meta name="citation_keywords" content="Glycogen phosphorylase, liver form" /><meta name="citation_keywords" content="PYGL" /><meta name="citation_keywords" content="Glycogen Storage Disease Type VI" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Glycogen Storage Disease Type VI" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Emma Labrador" /><meta name="DC.Contributor" content="David A Weinstein" /><meta name="DC.Date" content="2019/11/27" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK5941/" /><meta name="description" content="Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzyme catalyzes the rate-limiting step in glycogen degradation, and deficiency of the enzyme in the untreated child is characterized by hepatomegaly, poor growth, ketotic hypoglycemia, elevated hepatic transaminases, hyperlipidemia, and low prealbumin level. GSD VI is usually a relatively mild disorder that presents in infancy and childhood; rare cases of more severe disease manifesting with recurrent hypoglycemia and marked hepatomegaly have been described. More common complications in the setting of suboptimal metabolic control include short stature, delayed puberty, osteopenia, and osteoporosis. Hepatic fibrosis commonly develops in GSD VI, but cirrhosis and hypertrophic cardiomyopathy are rare. Clinical and biochemical abnormalities may decrease with age, but ketosis and hypoglycemia can continue to occur." /><meta name="og:title" content="Glycogen Storage Disease Type VI" /><meta name="og:type" content="book" /><meta name="og:description" content="Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzyme catalyzes the rate-limiting step in glycogen degradation, and deficiency of the enzyme in the untreated child is characterized by hepatomegaly, poor growth, ketotic hypoglycemia, elevated hepatic transaminases, hyperlipidemia, and low prealbumin level. GSD VI is usually a relatively mild disorder that presents in infancy and childhood; rare cases of more severe disease manifesting with recurrent hypoglycemia and marked hepatomegaly have been described. More common complications in the setting of suboptimal metabolic control include short stature, delayed puberty, osteopenia, and osteoporosis. Hepatic fibrosis commonly develops in GSD VI, but cirrhosis and hypertrophic cardiomyopathy are rare. Clinical and biochemical abnormalities may decrease with age, but ketosis and hypoglycemia can continue to occur." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK5941/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gsd6/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK5941/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE883AFBE04143D10000000002890113.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK5941_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK5941_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gsd5/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gcps/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK5941_"><span class="title" itemprop="name">Glycogen Storage Disease Type VI</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: GSD VI</div><p class="contrib-group"><span itemprop="author">Emma Labrador</span>, RN and <span itemprop="author">David A Weinstein</span>, MD, MMSc.</p><a data-jig="ncbitoggler" href="#__NBK5941_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK5941_ai__"><div class="contrib half_rhythm"><span itemprop="author">Emma Labrador</span>, RN<div class="affiliation small">Connecticut Children&#x02019;s Medical Center<br />Hartford, Connecticut<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihctucitcennoc@rodarbale" class="oemail">gro.snerdlihctucitcennoc@rodarbale</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David A Weinstein</span>, MD, MMSc<div class="affiliation small">University of Connecticut;<br />Connecticut Children&#x02019;s Medical Center<br />Hartford, Connecticut<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.chcu@nietsniew" class="oemail">ude.chcu@nietsniew</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 23, 2009</span>; Last Update: <span itemprop="dateModified">November 27, 2019</span>.</p><p><em>Estimated reading time: 14 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gsd6.Summary" itemprop="description"><h2 id="_gsd6_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzyme catalyzes the rate-limiting step in glycogen degradation, and deficiency of the enzyme in the untreated child is characterized by hepatomegaly, poor growth, ketotic hypoglycemia, elevated hepatic transaminases, hyperlipidemia, and low prealbumin level. GSD VI is usually a relatively mild disorder that presents in infancy and childhood; rare cases of more severe disease manifesting with recurrent hypoglycemia and marked hepatomegaly have been described. More common complications in the setting of suboptimal metabolic control include short stature, delayed puberty, osteopenia, and osteoporosis. Hepatic fibrosis commonly develops in GSD VI, but cirrhosis and hypertrophic cardiomyopathy are rare. Clinical and biochemical abnormalities may decrease with age, but ketosis and hypoglycemia can continue to occur.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of GSD VI is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and/or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PYGL</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Some individuals with GSD VI may not require any treatment, but treatment with cornstarch and protein improves growth, stamina, and ameliorates biochemical abnormalities including hypoglycemia and ketosis. Even in those with no hypoglycemia, a bedtime dose of cornstarch improves energy and prevents ketosis.</p><p><i>Surveillance</i>: Monitoring of blood glucose and blood ketone levels at least several times per month during times of stress including illness, intense activity, periods of rapid growth, or any time at which intake of food is reduced. Annual liver ultrasound examinations should start at age five years. Bone density exam is recommended when puberty is complete.</p><p><i>Agents/circumstances to avoid</i>: Excessive amounts of simple sugars; glucagon administration as a rescue therapy for hypoglycemia; growth hormone therapy for short stature; contact sports when hepatomegaly is present.</p><p><i>Evaluation of relatives at risk</i>: If the family-specific pathogenic variants are known, it is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to at-risk sibs so that early treatment and avoidance of factors that exacerbate disease can be initiated.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>GSD VI is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="gsd6.Diagnosis"><h2 id="_gsd6_Diagnosis_">Diagnosis</h2><p>Glycogen storage disease type VI (formerly known as Hers disease) is a disorder affecting hepatic glycogenolysis due to a deficiency of glycogen phosphorylase. This critical enzyme catalyzes the rate-limiting step in glycogen degradation.</p><div id="gsd6.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Glycogen storage disease type VI (GSD VI) <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Poor growth</div></li><li class="half_rhythm"><div>Ketotic hypoglycemia</div></li><li class="half_rhythm"><div>Elevated hepatic transaminases</div></li><li class="half_rhythm"><div>Hyperlipidemia</div></li><li class="half_rhythm"><div>Low prealbumin level</div></li><li class="half_rhythm"><div>Abdominal ultrasound showing hepatomegaly with diffuse echogenicity</div></li></ul></div><div id="gsd6.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of GSD VI <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and/or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PYGL</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK5941/table/gsd6.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figgsd6Tmoleculargenetictestingusedin" rid-ob="figobgsd6Tmoleculargenetictestingusedin">Table 1</a>). Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted</b>
<b>testing</b> (single-gene testing or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p>A liver biopsy is reserved for those in whom the diagnosis cannot be confirmed by molecular genetic techniques [<a class="bk_pop" href="#gsd6.REF.kishnani.2019.772">Kishnani et al 2019</a>].</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of GSD VI is fairly broad, individuals with the distinctive findings described in <a href="#gsd6.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#gsd6.Option_1">Option 1</a>) whereas those with a phenotype indistinguishable from other inherited disorders with hepatomegaly are more likely to be diagnosed using genomic testing (see <a href="#gsd6.Option_2">Option 2</a>).</p><div id="gsd6.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of GSD VI, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>. Single-gene testing is recommended when the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is from a high-risk population (see <a href="#gsd6.Prevalence">Prevalence</a>) or has an affected relative.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PYGL</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Targeted analysis for the founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK5941/table/gsd6.T.notable_pygl_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figgsd6Tnotablepyglpathogenicvariants" rid-ob="figobgsd6Tnotablepyglpathogenicvariants">c.1620+1G&#x0003e;A</a> (also known as IVS13+1G&#x0003e;A), can be performed first in individuals of Mennonite ancestry.</div></li><li class="half_rhythm"><div class="half_rhythm">A <b>glycogen storage disease <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PYGL</i> and other genes of interest (see <a href="#gsd6.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="gsd6.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by glycogen storage disorder, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="gsd6.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Glycogen Storage Disease Type VI</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PYGL</i></td><td headers="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_gsd6.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown but rare&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gsd6.TF.1.1"><p class="no_margin">See <a href="/books/NBK5941/#gsd6.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="gsd6.TF.1.2"><p class="no_margin">See <a href="#gsd6.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="gsd6.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="gsd6.TF.1.4"><p class="no_margin">Data derived from personal experience and the Human Gene Mutation Database [<a class="bk_pop" href="#gsd6.REF.stenson.2017.665">Stenson et al 2017</a>]</p></div></dd><dt>5. </dt><dd><div id="gsd6.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="gsd6.Clinical_Characteristics"><h2 id="_gsd6_Clinical_Characteristics_">Clinical Characteristics</h2><div id="gsd6.Clinical_Description"><h3>Clinical Description</h3><p><b>Typical presentation.</b> Glycogen storage disease type VI (GSD VI) is usually a relatively mild disorder presenting in infancy and childhood with abdominal distention, hepatomegaly, and growth restriction.</p><p><b>Hypoglycemia.</b> If present, hypoglycemia is mild and may manifest during an illness after prolonged fasting. Ketotic hypoglycemia after an overnight fast is the salient feature of this disorder.</p><p><b>Liver concerns</b></p><ul><li class="half_rhythm"><div><b>Fibrosis/cirrhosis occurrence.</b> Fibrosis commonly develops in GSD VI, but cirrhosis is rare [<a class="bk_pop" href="#gsd6.REF.roscher.2014.171">Roscher et al 2014</a>, <a class="bk_pop" href="#gsd6.REF.wilson.2019.1544">Wilson et al 2019</a>].</div></li><li class="half_rhythm"><div><b>Tumor risk.</b> While rare, hepatic adenomas and hepatocellular carcinoma can develop [<a class="bk_pop" href="#gsd6.REF.manzia.2011.1181">Manzia et al 2011</a>, <a class="bk_pop" href="#gsd6.REF.roscher.2014.171">Roscher et al 2014</a>].</div></li></ul><p><b>Muscle concerns</b></p><ul><li class="half_rhythm"><div><b>Muscle hypotonia and</b>
<b>fatigue with exercise</b> have been reported [<a class="bk_pop" href="#gsd6.REF.beauchamp.2007.722">Beauchamp et al 2007</a>]. Delay in motor milestones may occur in untreated children.</div></li><li class="half_rhythm"><div><b>Muscle cramping</b> is a common complaint in GSD VI if protein deficiency is present. The cramping is usually in the lower extremities and typically occurs with activity and overnight [DA Weinstein, unpublished data].</div></li><li class="half_rhythm"><div><b>Hypertrophic cardiomyopathy.</b> Secondary muscle involvement can occur from over-storage of glycogen. Rare cases of hypertrophic cardiomyopathy have been reported [<a class="bk_pop" href="#gsd6.REF.roscher.2014.171">Roscher et al 2014</a>].</div></li></ul><p><b>Growth</b></p><ul><li class="half_rhythm"><div><b>In untreated individuals.</b> Poor growth and delayed puberty are common findings.</div></li><li class="half_rhythm"><div><b>With treatment</b></div><ul><li class="half_rhythm"><div>Growth normalizes;</div></li><li class="half_rhythm"><div>Final height is usually appropriate for genetic potential.</div></li></ul></li></ul><p><b>Skeletal concerns</b></p><ul><li class="half_rhythm"><div>Osteopenia and osteoporosis are common in untreated individuals.</div></li><li class="half_rhythm"><div>Bone mineral density can normalize with treatment [<a class="bk_pop" href="#gsd6.REF.chen.2016">Chen &#x00026; Weinstein 2016</a>].</div></li></ul><p><b>Renal concerns</b></p><ul><li class="half_rhythm"><div>Due to the over-storage of glycogen and high protein diet, the consensus guidelines recommend screening for renal disease.</div></li><li class="half_rhythm"><div>Renal abnormalities including proteinuria, however, are rarely seen in GSD VI [<a class="bk_pop" href="#gsd6.REF.okechuku.2017.703">Okechuku et al 2017</a>].</div></li></ul><p><b>Intellectual development</b> is normal in most children.</p><p><b>Atypical form.</b> Rare variants with severe and recurrent hypoglycemia, severe hepatomegaly, and postprandial hyperlactatemia have been described [<a class="bk_pop" href="#gsd6.REF.beauchamp.2007.722">Beauchamp et al 2007</a>].</p><p><b>Adulthood.</b> Clinical and biochemical abnormalities may improve with age and many adults are asymptomatic.</p></div><div id="gsd6.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists.</p><p>The Mennonite <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK5941/table/gsd6.T.notable_pygl_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figgsd6Tnotablepyglpathogenicvariants" rid-ob="figobgsd6Tnotablepyglpathogenicvariants">c.1620+1G&#x0003e;A</a> generates a transcript lacking all or part of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 13 while maintaining the reading frame. Either protein isoform is expected to have some residual enzyme activity, which may explain the milder GSD VI <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the Mennonite population [<a class="bk_pop" href="#gsd6.REF.chang.1998.865">Chang et al 1998</a>].</p></div><div id="gsd6.Nomenclature"><h3>Nomenclature</h3><p>GSD VI (Hers disease) was first reported by <a class="bk_pop" href="#gsd6.REF.hers.1959.35">Hers [1959]</a> and <a class="bk_pop" href="#gsd6.REF.stetten.1960.505">Stetten &#x00026; Stetten [1960]</a>. GSD VI was referred to as Hers disease based on Hers&#x02019; prediction that the GSDs were a heterogeneous group that would ultimately be categorized into specific types.</p><p>GSD VI now refers to liver glycogen phosphorylase deficiency.</p></div><div id="gsd6.Prevalence"><h3>Prevalence</h3><p>Liver glycogen phosphorylase deficiency affects approximately 1:65,000-1:85,000 live births; hoever, many people with this condition are undiagnosed. GSD VI is equally prevalent in males and females. The Mennonite population is at increased risk for GSD VI, with a prevalence of 1:1,000 resulting from the <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> <a class="figpopup" href="/books/NBK5941/table/gsd6.T.notable_pygl_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figgsd6Tnotablepyglpathogenicvariants" rid-ob="figobgsd6Tnotablepyglpathogenicvariants">c.1620+1G&#x0003e;A</a>. It is estimated that 3% of the Mennonite population are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (i.e., are carriers) for this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#gsd6.REF.chang.1998.865">Chang et al 1998</a>]. There also appears to be an increased prevalence of GSD VI in Scotland and Northern Africa, but the frequency is not known [<a class="bk_pop" href="#gsd6.REF.chen.2016">Chen &#x00026; Weinstein 2016</a>].</p></div></div><div id="gsd6.Genetically_Related_Allelic_Disorde"><h2 id="_gsd6_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>PYGL</i>.</p></div><div id="gsd6.Differential_Diagnosis"><h2 id="_gsd6_Differential_Diagnosis_">Differential Diagnosis</h2><div id="gsd6.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Glycogen Storage Disease Type VI</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/GSD VI</th><th headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from GSD VI</th></tr></thead><tbody><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phosphorylase kinase deficiency (<a href="/books/n/gene/gsd9/">GSD IX</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PHKA2</i><br /><i>PHKB</i><br /><i>PHKG2</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL<br />AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Fasting ketosis</div></li><li class="half_rhythm"><div>Hypoglycemia</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li><li class="half_rhythm"><div>&#x02191; lipids</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Male predominance</div></li><li class="half_rhythm"><div>AST &#x00026; ALT commonly more severely &#x02191;</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hepatic glycogen synthase deficiency (GSD 0)<br />(OMIM <a href="https://omim.org/entry/240600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">240600</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GYS2</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Fasting hypoglycemia</div></li><li class="half_rhythm"><div>Ketosis</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Absence of hepatomegaly</div></li><li class="half_rhythm"><div>Postprandial hyperglycemia &#x00026; hyperlactatemia</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glucose-6-phosphatase deficiency (<a href="/books/n/gene/gsd1/">GSD Ia</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>G6PC</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Fasting hypoglycemia</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li><li class="half_rhythm"><div>Hyperlipidemia</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Severe fasting lactic acidosis</div></li><li class="half_rhythm"><div>Hyperuricemia</div></li><li class="half_rhythm"><div>Marked hyperlipidemia</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glucose-6-phosphate transporter deficiency (<a href="/books/n/gene/gsd1/">GSD Ib</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC37A4</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Fasting hypoglycemia</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li><li class="half_rhythm"><div>Hyperlipidemia</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neutropenia</div></li><li class="half_rhythm"><div>Crohn&#x02019;s disease</div></li><li class="half_rhythm"><div>Hyperuricemia</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Debranching enzyme deficiency (<a href="/books/n/gene/gsd3/">GSD III</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AGL</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Fasting hypoglycemia</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li><li class="half_rhythm"><div>Hyperlipidemia</div></li><li class="half_rhythm"><div>Low prealbumin</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>AST &#x00026; ALT usually markedly &#x02191;</div></li><li class="half_rhythm"><div>Muscle involvement w/&#x02191; CK</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Branching enzyme deficiency (<a href="https://www.ncbi.nlm.nih.gov/books/NBK115333/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GSD IV</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GBE1</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li><li class="half_rhythm"><div>&#x02193; prealbumin</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lack of hypoglycemia until end-stage liver disease</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GLUT2 deficiency (Fanconi-Bickel syndrome; GSD XI) (OMIM <a href="https://omim.org/entry/227810" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">227810</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC2A2</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Fasting hypoglycemia</div></li><li class="half_rhythm"><div>Fasting ketosis</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li><li class="half_rhythm"><div>Low prealbumin</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Postprandial hyperglycemia</div></li><li class="half_rhythm"><div>Chronic diarrhea</div></li><li class="half_rhythm"><div>Hypophosphatemic rickets</div></li><li class="half_rhythm"><div>Fanconi nephropathy</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fructose-1,6-bisphosphatase deficiency&#x000a0;<sup>1</sup> (OMIM <a href="https://omim.org/entry/229700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">229700</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBP1</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Fasting hypoglycemia</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fasting hyperlactatemia</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpha1-a/">Alpha-1 antitrypsin deficiency</a>-related hepatitis&#x000a0;<sup>2</sup></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SERPINA1</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>&#x02191; AST/ALT</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lack of fasting hypoglycemia &#x00026; ketosis</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glycerol kinase deficiency (OMIM <a href="https://omim.org/entry/307030" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">307030</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GK</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoglycemia</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketoacidosis &#x00026; extremely &#x02191; glycerol</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PRKAG2 deficiency (see <a href="/books/n/gene/hyper-card/">Hypertrophic Cardiomyopathy Overview</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKAG2</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Nonlysosomal glycogen accumulation primarily in skeletal &#x00026; cardiac muscle</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ventricular pre-excitation &#x00026; mild-to-severe cardiac hypertrophy</div></li><li class="half_rhythm"><div>No hypoglycemia</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Niemann-Pick disease type B&#x000a0;<b><sup>3</sup></b> (see <a href="/books/n/gene/npab/">ASM Deficiency</a>)</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMPD1</i></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Growth failure</div></li><li class="half_rhythm"><div>Hyperlipidemia</div></li></ul>
</td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>No fasting hypoglycemia</div></li><li class="half_rhythm"><div>Significant splenomegaly</div></li><li class="half_rhythm"><div>Bone &#x00026; pulmonary involvement</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gaucher/">Gaucher disease</a>&#x000a0;<b><sup>3</sup></b></td><td headers="hd_h_gsd6.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GBA</i></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Adapted from <a class="bk_pop" href="#gsd6.REF.kishnani.2019.772">Kishnani et al [2019]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ASM = acid sphingomyelinase; GSD = glycogen storage disease; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="gsd6.TF.2.1"><p class="no_margin">Fructose-1,6-bisphosphatase deficiency is one example of a disorder of gluconeogenesis; other should also be considered.</p></div></dd><dt>2. </dt><dd><div id="gsd6.TF.2.2"><p class="no_margin">Alpha-1 antitrypsin deficiency-related hepatitis is one example of a primary liver disease; other primary liver diseases should also be considered.</p></div></dd><dt>3. </dt><dd><div id="gsd6.TF.2.3"><p class="no_margin">Niemann-Pick disease type B and Gaucher disease are examples of metabolic storage disorders; other metabolic storage disorders should also be considered.</p></div></dd></dl></div></div></div><p><b>Mitochondrial disorders</b> should also be considered in the differential diagnosis of GSD VI (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>).</p></div><div id="gsd6.Management"><h2 id="_gsd6_Management_">Management</h2><div id="gsd6.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with glycogen storage disease type VI (GSD VI), the evaluations summarized in <a class="figpopup" href="/books/NBK5941/table/gsd6.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figgsd6Trecommendedevaluationsfollowing" rid-ob="figobgsd6Trecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="gsd6.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with GSD VI</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.T.recommended_evaluations_following_lrgtbl__"><table><thead><tr><th id="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">System/Concern</th><th id="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Hepatic</b></td><td headers="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Assessment of liver size</div></li><li class="half_rhythm"><div>Abdominal ultrasound</div></li></ul>
</td><td headers="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Involvement of specialists in GSD VI (gastroenterologist, endocrinologist, metabolic geneticist)</td></tr><tr><td headers="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_gsd6.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr></tbody></table></div></div></div><div id="gsd6.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Note: Some individuals with GSD VI may not require any treatment, but most have better growth and stamina with therapy.</p><div id="gsd6.T.treatment_of_manifestations_in_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in individuals with GSD VI</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.T.treatment_of_manifestations_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.T.treatment_of_manifestations_in_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestations/<br />Concern</th><th id="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypoglycemia</b></td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Frequent small meals</div></li><li class="half_rhythm"><div>Uncooked cornstarch (1-1.5 g/kg) 1-4x/day</div></li><li class="half_rhythm"><div>Protein 2-3 g/kg body weight per day</div></li><li class="half_rhythm"><div>Glycosade&#x000a0;<sup>1</sup> from waxy maize, proven beneficial in children age &#x0003e;5 yrs &#x00026; adults to extend overnight fast duration</div></li></ul>
</td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Doses adjusted to keep glucose concentrations at 75-100 mg/dL (4.2-5.6 mmol/L) &#x00026; beta-OH-butyrate concentrations &#x02264;0.2 mmol/L</td></tr><tr><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hepatomegaly</b></td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Restricted intake of simple sugars (&#x0003c;5 g)</div></li><li class="half_rhythm"><div>Restricted intake of total carbohydrates (15-30 g per meal)</div></li></ul>
</td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To &#x02193; liver size</td></tr><tr><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b><br /><b>restriction</b></td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cornstarch &#x00026; protein supplementation</td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Growth normalizes w/treatment</div></li><li class="half_rhythm"><div>Growth hormone contraindicated</div></li></ul>
</td></tr><tr><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Decreased</b><br /><b>bone density</b></td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cornstarch &#x00026; protein supplementation</div></li><li class="half_rhythm"><div>Calcium &#x00026; Vitamin D</div></li></ul>
</td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primarily due to ketosis</td></tr><tr><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Muscle</b><br /><b>cramping</b></td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein 2-3 grams per kg body weight per day</td><td headers="hd_h_gsd6.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle cramping is usually due to undertreatment &#x00026; protein deficiency.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gsd6.TF.4.1"><p class="no_margin">Extended-release cornstarch</p></div></dd></dl></div></div></div><div id="gsd6.General_Nutrition_Recommendations"><h4>General Nutrition Recommendations</h4><p>[<a class="bk_pop" href="#gsd6.REF.kishnani.2019.772">Kishnani et al 2019</a>]</p><p><b>Protein</b></p><ul><li class="half_rhythm"><div>Diet should be high in protein and provide 2-3 g protein/kg body weight or 20%-25% of total calories.</div></li><li class="half_rhythm"><div>Protein intake should be distributed throughout the day.</div></li><li class="half_rhythm"><div>Protein should be consumed at each meal and snack, before bedtime, and before physical activities.</div></li></ul><p><b>Carbohydrates</b></p><ul><li class="half_rhythm"><div>Carbohydrates should provide 45%-50% of total calories.</div></li><li class="half_rhythm"><div>Complex carbohydrates should be consumed with each meal to provide a sustained source.</div></li><li class="half_rhythm"><div>Overtreatment with cornstarch can be detrimental.</div></li><li class="half_rhythm"><div>Small amounts of dairy and fruits are allowed in the diet.</div></li><li class="half_rhythm"><div>Simple sugars should be limited to 5 g.</div></li></ul><p><b>Fats</b></p><ul><li class="half_rhythm"><div>Fats should provide 25%-30%of total calories.</div></li><li class="half_rhythm"><div>Diet should include good sources of poly-and mono-unsaturated fatty acids.</div></li><li class="half_rhythm"><div>Saturated fats should provide &#x0003c;10% of total calories.</div></li><li class="half_rhythm"><div>Cholesterol should be restricted to &#x0003c;300 mg/day.</div></li></ul></div></div><div id="gsd6.Surveillance"><h3>Surveillance</h3><div id="gsd6.T.recommended_surveillance_for_indi" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with GSDVI</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.T.recommended_surveillance_for_indi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.T.recommended_surveillance_for_indi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ketosis</b></td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blood ketone level upon wakening using portable blood ketone meter.</td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least several times per month&#x000a0;<sup>1</sup>; goal is to maintain blood beta-OH-butyrate concentrations &#x0003c;0.3 mmol/L.</td></tr><tr><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypoglycemia</b></td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Self-glucose monitoring</td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least several times per month &#x00026; as needed&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Liver ultrasound</td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually beginning at age 5 yrs</td></tr><tr><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bone density</td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">When puberty is complete &#x00026; as clinically indicated</td></tr><tr><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal</b></td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24-hr urine to screen for microalbuminuria</td><td headers="hd_h_gsd6.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gsd6.TF.5.1"><p class="no_margin">Glucose and ketone levels should also be measured during times of stress including illness, intense activity, periods of rapid growth, or any time at which intake of food is reduced and before and after changes are made to the amount of cornstarch or protein intake. Monitoring recommendations should be tailored to individual patient needs.</p></div></dd></dl></div></div></div></div><div id="gsd6.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Excessive amounts of simple sugars to prevent excessive hepatic glycogen deposition</div></li><li class="half_rhythm"><div>Glucagon administration as a rescue therapy for hypoglycemia because blood glucose concentrations will not increase</div></li><li class="half_rhythm"><div>Growth hormone for short stature because it usually exacerbates ketosis and may increase the risk of complications</div></li><li class="half_rhythm"><div>Contact sports when hepatomegaly is present (or use appropriate cautions)</div></li></ul></div><div id="gsd6.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic at-risk sibs to identify as early as possible those who would benefit from prompt initiation of treatment and avoidance of factors that exacerbate disease.</p><p>Molecular genetic testing is indicated if the pathogenic variants in the family are known.</p><p>See <a href="#gsd6.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gsd6.Pregnancy_Management"><h3>Pregnancy Management</h3><p>A pregnant woman with GSD VI must be vigilant in monitoring for hypoglycemia and ketosis during pregnancy. Cornstarch and protein supplementation (2-4x/day) are needed during pregnancy to prevent ketosis and premature labor. The goal is to maintain euglycemia throughout pregnancy to prevent morbidity and mortality to the fetus due to activation of counterregulatory hormones resulting in lipolysis and ketosis. Increasing protein intake may be necessary to provide an alternate source of glucose via gluconeogenesis.</p></div><div id="gsd6.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>An extended-release cornstarch preparation is presently being tested as part of the Clinical Trials <a href="https://clinicaltrials.gov/ct2/show/NCT02318966?term=NCT02318966&#x00026;draw=1&#x00026;rank=1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GLYDE study</a>. This experimental product may improve maintenance of normoglycemia with fasting for a longer duration and may reduce the number of doses of cornstarch required.</p><p>There is also an ongoing trial looking for a biomarker for glycogen storage disease (<a href="https://clinicaltrials.gov/ct2/show/NCT02385162?term=NCT02385162&#x00026;draw=1&#x00026;rank=1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NCT02385162</a>).</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="gsd6.Genetic_Counseling"><h2 id="_gsd6_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gsd6.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Glycogen storage disease type VI (GSD VI) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="gsd6.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>PYGL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with GSD VI are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PYGL</i>.</div></li><li class="half_rhythm"><div>A higher <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> for GSD VI exists in the Mennonite population (see <a href="#gsd6.Prevalence">Prevalence</a>), increasing the risk that an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have a reproductive partner who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PYGL</i>. If the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is heterozygous for a <i>PYGL</i> pathogenic variant, offspring are at 50% risk of being affected and 50% risk of being carriers.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>PYGL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="gsd6.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>PYGL</i> pathogenic variants in the family.</p><p><b>Biochemical testing</b> is not reliable for <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a>.</p></div><div id="gsd6.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#gsd6.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="gsd6.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p><b>Molecular genetic testing.</b> Once the <i>PYGL</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p><b>Biochemical testing</b> is not reliable for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a><b>.</b></p></div></div><div id="gsd6.Resources"><h2 id="_gsd6_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association for Glycogen Storage Disease (AGSD)</b></div><div>PO Box 896</div><div>Durant IA 52747</div><div><b>Phone:</b> 563-514-4022</div><div><b>Email:</b> maryc@agsdus.org</div><div><a href="http://www.agsdus.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.agsdus.org</a></div></li><li class="half_rhythm"><div><b>Association for Glycogen Storage Disease UK (AGSD-UK)</b></div><div>9 Lindop Road</div><div>Altrincham Cheshire WA15 9DZ</div><div>United Kingdom</div><div><b>Phone:</b> 0161 980 7303</div><div><a href="http://www.agsd.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.agsd.org.uk</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li><li class="half_rhythm"><div><b>University of Florida GSD International Natural History Registry</b></div><div><b>Phone:</b> 352-273-6655</div><div><b>Email:</b> lfiske@peds.ufl.edu</div></li></ul></div><div id="gsd6.Molecular_Genetics"><h2 id="_gsd6_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gsd6.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Glycogen Storage Disease Type VI: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gsd6.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gsd6.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gsd6.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gsd6.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_gsd6.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gsd6.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gsd6.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5836" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PYGL</i></a></td><td headers="hd_b_gsd6.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5836" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_gsd6.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P06737" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Glycogen phosphorylase, liver form</a></td><td headers="hd_b_gsd6.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PYGL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PYGL database</a></td><td headers="hd_b_gsd6.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PYGL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PYGL</a></td><td headers="hd_b_gsd6.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PYGL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PYGL</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gsd6.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gsd6.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Glycogen Storage Disease Type VI (<a href="/omim/232700,613741" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/232700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">232700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLYCOGEN STORAGE DISEASE VI; GSD6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613741" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613741</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLYCOGEN PHOSPHORYLASE, LIVER; PYGL</td></tr></tbody></table></div></div><div id="gsd6.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Glycogen phosphorylase, which requires pyridoxal phosphate as a cofactor, cleaves the &#x003b1;(1&#x02192;4) glycosidic bonds between the glycosyl residues at the periphery of the glycogen molecule to release glucose-1-phosphate. This enzymatic reaction is the rating-limiting process in glycogenolysis, and it is repeated until the proximal four residues before the branch point of that particular glycogen chain are reached. The three <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of glycogen phosphorylase &#x02013; muscle, liver, and brain &#x02013; are encoded by different genes.</p><p>Liver glycogen phosphorylase, encoded by <i>PYGL</i>, forms a homodimer that has a regulatory <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and a catalytic domain:</p><ul><li class="half_rhythm"><div><b>Regulatory <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a></b></div><ul><li class="half_rhythm"><div>Contains the phosphorylation peptide and the AMP binding site;</div></li><li class="half_rhythm"><div>Interacts with the phosphorylase kinase, allosteric effectors, and phosphatase.</div></li></ul></li><li class="half_rhythm"><div><b>Catalytic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a></b> binds to glycogen.</div></li></ul><p><b>Mechanism of disease causation.</b> GSD VI results from a loss of function of liver glycogen phosphorylase [<a class="bk_pop" href="#gsd6.REF.burwinkel.1998.785">Burwinkel et al 1998</a>, <a class="bk_pop" href="#gsd6.REF.beauchamp.2007.722">Beauchamp et al 2007</a>]. Most pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants affecting activation or binding of substrate or pyrophosphate.</p><div id="gsd6.T.notable_pygl_pathogenic_variants" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Notable <i>PYGL</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK5941/table/gsd6.T.notable_pygl_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gsd6.T.notable_pygl_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/nm_002863.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002863<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/71037379" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002854<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1620+1G&#x0003e;A<br />(IVS13+1G&#x0003e;A)</td><td headers="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_gsd6.T.notable_pygl_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mennonite <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#gsd6.REF.chang.1998.865">Chang et al 1998</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="gsd6.TF.6.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div></div></div><div id="gsd6.References"><h2 id="_gsd6_References_">References</h2><div id="gsd6.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.beauchamp.2007.722">Beauchamp NJ, Taybert J, Champion MP, Layet V, Heinz-Erian P, Dalton A, Tanner MS, Pronicka E, Sharrard MJ. High frequency of missense mutations in glycogen storage disease type VI. <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:722–34.</span> [<a href="/pubmed/17705025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17705025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.burwinkel.1998.785">Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:785–91.</span> [<a href="/pmc/articles/PMC1377030/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377030</span></a>] [<a href="/pubmed/9529348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9529348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.chang.1998.865">Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:865–70.</span> [<a href="/pubmed/9536091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9536091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.chen.2016">Chen MA, Weinstein DA. Glycogen storage diseases: diagnosis, treatment, and outcome. Transl Sci Rare Dis 2016;1:45-72. Available <a href="https://content.iospress.com/articles/translational-science-of-rare-diseases/trd006" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. Accessed 11-21-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.hers.1959.35">Hers HG. <span><span class="ref-journal">Rev Int Hepatol. </span>1959;<span class="ref-vol">9</span>:35–55.</span> [Enzymatic studies of hepatic fragments; application to the classification of glycogenoses.] [<a href="/pubmed/13646331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13646331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.kishnani.2019.772">Kishnani PS, Goldstein J, Austin SL, Arn P, Bachrach B, Bali DS, Chung WK, El-Gharbawy A, Bown LM, Kahler S, Pendyal S, Ross KM, Tsilianidis L, Weinstein DA, Watson MS, et al.  Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). <span><span class="ref-journal">Genet Med. </span>2019;<span class="ref-vol">21</span>:772–89.</span> [<a href="/pubmed/30659246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30659246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.manzia.2011.1181">Manzia TM, Angelico R, Toti L, Cillis A, Ciano P, Orlando G, Anselmo A, Angelico M, Tisone G. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. <span><span class="ref-journal">Transplant Proc. </span>2011;<span class="ref-vol">43</span>:1181–3.</span> [<a href="/pubmed/21620082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21620082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.okechuku.2017.703">Okechuku GO, Shoemaker LR, Dambska M, Brown LM, Mathew J, Weinstein DA. Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy. <span><span class="ref-journal">J Inherit Metab Dis. </span>2017;<span class="ref-vol">40</span>:703–8.</span> [<a href="/pubmed/28612263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28612263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.roscher.2014.171">Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, Raiman J, Schulze A, Siriwardena K, Mercimek-Mahmutoglu S. The natural history of glycogen storage disease type VI and IX: Long-term outcome from the largest metabolic center in Canada. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">113</span>:171–6.</span> [<a href="/pubmed/25266922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25266922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.stenson.2017.665">Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. <span><span class="ref-journal">Hum Genet. </span>2017;<span class="ref-vol">136</span>:665–77.</span> [<a href="/pmc/articles/PMC5429360/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5429360</span></a>] [<a href="/pubmed/28349240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28349240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.stetten.1960.505">Stetten D Jr, Stetten MR. Glycogen metabolism. <span><span class="ref-journal">Physiol Rev. </span>1960;<span class="ref-vol">40</span>:505–37.</span> [<a href="/pubmed/13834511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13834511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gsd6.REF.wilson.2019.1544">Wilson LH, Cho JH, Estrella A, Smyth JA, Wu R, Chengsupanimit T, Brown LM, Weinstein DA, Lee YM. Liver glycogen phosphorylase deficiency leads to profibrogenic phenotype in a murine model of glycogen storage disease type VI. <span><span class="ref-journal">Hepatol Commun. </span>2019;<span class="ref-vol">3</span>:1544–55.</span> [<a href="/pmc/articles/PMC6824077/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6824077</span></a>] [<a href="/pubmed/31701076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31701076</span></a>]</div></li></ul></div></div><div id="gsd6.Chapter_Notes"><h2 id="_gsd6_Chapter_Notes_">Chapter Notes</h2><div id="gsd6.Acknowledgments"><h3>Acknowledgments</h3><p>The authors also wish to thank Drs Holmes Morton and Kevin Strauss for sharing their experience with the Mennonite population.</p></div><div id="gsd6.Author_History"><h3>Author History</h3><p>Aditi I Dagli, MD; University of Florida (2009-2019)<br />Emma Labrador, RN (2019-present)<br />David A Weinstein, MD, MMSc (2009-present)</p></div><div id="gsd6.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>27 November 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 May 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 April 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>4 February 2009 (ad) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK5941</span><span class="label">PMID: <a href="/pubmed/20301760" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301760</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gsd5/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gcps/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK5941&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK5941/?report=reader">PubReader</a></li><li><a href="/books/NBK5941/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK5941" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK5941" style="display:none" title="Cite this Page"><div class="bk_tt">Labrador E, Weinstein DA. Glycogen Storage Disease Type VI. 2009 Apr 23 [Updated 2019 Nov 27]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK5941/pdf/Bookshelf_NBK5941.pdf">PDF version of this page</a> (445K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gsd6.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gsd6.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gsd6.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gsd6.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#gsd6.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gsd6.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gsd6.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gsd6.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gsd6.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gsd6.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gsd6.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5836[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PYGL</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK5941+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1477920" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1477920" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1477920" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1477920" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301788" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type III</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type III<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dagli A, Sentner CP, Weinstein DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23285490" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type IV</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type IV<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Magoulas PL, El-Hattab AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31804789" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bijarnia-Mahay S, Bhatia S, Arora V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301760" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301760" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0419acdd21425a255a9c42">Glycogen Storage Disease Type VI - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Glycogen Storage Disease Type VI - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:23:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE883AFBE04143D10000000002890113&amp;ncbi_session=CE883AFBE0419AB1_0649SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK5941%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK5941&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK5941/&amp;ncbi_pagename=Glycogen Storage Disease Type VI - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE883AFBE0419AB1_0649SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>